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Weight change in control group participants in
behavioural weight loss interventions: a
systematic review and meta-regression study
Lauren Waters1*†, Alexis St George2†, Tien Chey2† and Adrian Bauman2†
Abstract
Background: Unanticipated control group improvements have been observed in intervention trials targeting
various health behaviours. This phenomenon has not been studied in the context of behavioural weight loss
intervention trials. The purpose of this study is to conduct a systematic review and meta-regression of behavioural
weight loss interventions to quantify control group weight change, and relate the size of this effect to specific trial
and sample characteristics.
Methods: Database searches identified reports of intervention trials meeting the inclusion criteria. Data on control
group weight change and possible explanatory factors were abstracted and analysed descriptively and
quantitatively.
Results: 85 trials were reviewed and 72 were included in the meta-regression. While there was no change in
control group weight, control groups receiving usual care lost 1 kg more than control groups that received no
intervention, beyond measurement.
Conclusions: There are several possible explanations why control group changes occur in intervention trials
targeting other behaviours, but not for weight loss. Control group participation may prevent weight gain, although
more research is needed to confirm this hypothesis.
Background
The increasing prevalence of overweight and obesity has
become a cause for concern over the past decade [1]
with overweight and obesity being major determinants
of a number of chronic health conditions including
hypertension, cardiovascular disease, diabetes and cancer
[2]. The importance of implementing interventions to
address this public health problem has been recognised
by the World Health Organization [1,3] and the US Sur-
geon General [4]. Consequently, there is now an exten-
sive body of literature addressing the efficacy of
behavioural approaches to obesity prevention and treat-
ment through encouraging increased physical activity
and reduced energy intake. Such research is usually con-
ducted as randomized trials, where participants receiving
an intervention are compared to a control group who re-
ceive no treatment or current best practice (usual care)
[5,6].
Unanticipated improvements in the behaviour of con-
trol group participants have been observed in inter-
vention trials targeting an array of behaviours, including
hazardous drinking [7], antiretroviral therapy adher-
ence [8], physical activity [9], and chronic disease self-
management [10]. Such improvements may occur in
response to undergoing baseline assessment; due to par-
ticipants’ awareness of being involved in an experimental
trial; or due to the delivery of more intensive ‘usual care’
than would be encountered beyond the research context
[11]. It is possible that control group improvements may
also occur in behavioural weight loss intervention trials.
Control group improvements have the potential to reduce
or even nullify intervention effects through reducing stat-
istical power to detect significant effects. Therefore, un-
derstanding when and why control group improvements
occur has important implications for researchers, not
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only with respect to the interpretation of intervention
effects, but also in relation to the design of future behav-
ioural weight loss intervention trials.
Reviews of the behavioural weight loss intervention lit-
erature have alluded to the fact control group par-
ticipants may lose weight through participating in an
intervention trial [12]. However, there have been no
systematic investigations specifically addressing weight
change in control group participants in behavioural
weight loss intervention trials. Nor has an attempt been
made to quantify the amount of weight change that can
be expected for participants not receiving the interven-
tion; or to identify factors that are likely to predict a
greater amount of weight change (particularly weight
loss) among control group participants. The first object-
ive of this study is to systematically review the behav-
ioural weight loss intervention literature in order to
describe the associations between control group weight
change and specific trial and sample characteristics. The
second objective is to conduct a meta-analysis to quan-
tify the amount of weight change that occurs only in
control groups, and a meta-regression analysis to relate
the size of this effect to specific trial and sample charac-
teristics. This meta-analysis will not compare interven-
tion group effect sizes with control group effect sizes as
the aim of this study is not to draw conclusions on the
effectiveness of behavioural interventions in achieving
weight loss, but to examine the amount of weight
change that occurs solely due to (control group) partici-
pation in such trials.
Methods
Criteria for inclusion
Reports of randomised controlled trials or quasi-
experimental trials evaluating behavioural weight loss
interventions targeting adult participants, and that were
published in English between 2005 and 2010 were po-
tentially eligible for inclusion in this review. An exten-
sive number of behavioural weight loss interventions
have been published and the decision to limit the review
to papers that were published within this time frame
was guided by practical considerations.
Intervention trials were excluded from the review if
the primary objective of the trial was not weight reduc-
tion; or if they implemented strategies other than behav-
iour change in order to achieve weight reduction (e.g.,
intervention components included pharmacological ther-
apy, nutritional supplementation, herbal remedies or
surgery). Trials were also excluded if they did not recruit
a control or usual care group, or if participants allocated
to the comparison condition received an alternative be-
havioural weight loss intervention or an attention con-
trol condition. Trials that did not report, or provide
sufficient information to enable calculation of weight
change (in kilograms) from baseline to follow up for
each group were also excluded. Finally, trials recruiting
participants who were pregnant or lactating, or had a
medical condition which could confound the effect of a
weight loss intervention (e.g., Prader Willi syndrome)
were also excluded. No restriction was placed on the
duration of trials; however, for trials that reported out-
comes post-intervention and following a period of main-
tenance where no intervention was delivered, weight
changes reported immediately following the intervention
(not following the maintenance period) were used. This
was done in order to standardise the definition of inter-
vention duration for trials with and without a mainten-
ance period.
Electronic searches
Electronic databases (Pub Med [1951], Web of Science
[1981], EMBASE [1980], PsychINFO[1967])were searched
in December 2010 for reports of weight loss interven-
tion trials using a combination of the following Medical
Subject Headings (MeSH) and text words: (((obes* OR
overweight OR weight gain* OR weight los*OR weight
cycling OR weight reduc* OR weight maint*OR weight
decreas* OR body mass index OR adipos* OR overload
syndrom* OR weight watch* OR weight control*) AND
(exercise* OR exercise-therapy OR physical education*
OR physical fitness OR exertion* OR sport* OR walking
OR jogging OR swimming OR bicyc* OR cycling OR
weight lift* OR gymnastic* OR danc* OR strength train*
OR resistance train*OR aerobic train* OR Lifestyle OR
Health* educ* OR health* behav* OR health* promo-
t*OR nutrition* OR diet* OR diet therapy OR diabetic
diet) AND (random* OR clinical trial OR control group
OR meta analysis OR intervention OR random alloca-
tion OR intervention studies))).
Study selection
One person, LW, screened the titles and abstracts of
articles identified through electronic database searches.
Full text versions of reports of trials that appeared to be
relevant to the review were retrieved and read in full. A
checklist developed prior to the search, and based on
the list of inclusion and exclusion criteria, was used to
systematically identify papers for inclusion. A second
person (AS) independently screened 15% of the articles
(selected at random) and agreement between reviewers
was 100%.
Data abstraction
Data was abstracted and coded by two reviewers (LW
and AS). The primary outcome variable was mean weight
change in kilograms from baseline to post-intervention
follow up. Where this variable was not reported, but the
mean weight for each group at baseline and follow up
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was given, change was calculated. For trials that reported
weight in pounds, a conversion to kilograms was under-
taken. Information on characteristics that were hypothe-
sised to be potentially associated with control group
weight change was recorded, and categorised as being
related to trial design, treatment of the control group, or
characteristics of the enrolled participants.
Trial design and methodology
Weight loss interventions were evaluated using ran-
domised controlled trials or quasi-experimental (non-
randomised controlled) trials. Participant recruitment
strategies were categorised as being either an approach
that involved identifying potential participants through
searches of existing registers (e.g., general practice lists
or existing trial cohorts) or appealing to volunteers
through the media or by contacting existing community
organisations (such as schools, workplaces or churches).
Trial duration was defined as the length of time from
baseline to immediate post-intervention follow up (ex-
cluding any period of maintenance). Sample size and the
number of times a participant underwent assessment of
body weight were also recorded.
Control group treatment
The description of the treatment delivered to the control
group was categorised as being a “no intervention con-
trol” condition, “waiting list control” condition or “usual
care”. To be categorised as a no intervention control
group, participants allocated to this group must have
received no treatment other than undergoing assess-
ments. Similarly, participants in a waiting list control
group received no treatment during the trial, but were
informed that they would have the opportunity to re-
ceive the intervention components following the com-
pletion of the study. Participants allocated to a usual
care control group received the same level of treatment
that a person would normally have received, or could
have had access to, outside of the intervention context.
Usual care treatment may have included the issue of
standard print leaflets addressing topics related to diet
or physical activity, brief education sessions addressing
topics such as risk factors for chronic disease, or advice
to maintain usual behaviour patterns.
Characteristics of participants
Information on participants’ baseline characteristics, in-
cluding age, gender, health status and body mass index,
were abstracted and coded. The mean age of the sample
in each trial was recorded, as was the proportions of fe-
male participants. Baseline health status was determined
in the following way: participants in trials that specific-
ally aimed to recruit people with an existing medical or
psychiatric condition (e.g., cancer, diabetes, chronic heart
disease, schizophrenia, obstructive sleep apnoea) were
defined as having a chronic disease. In trials where re-
cruitment was not targeted towards people with an exist-
ing medical condition, but where the mean BMI of the
sample was in the overweight or obese range (BMI >
25 kg/m2) [13], participants were categorised as being at
risk of a chronic disease. For trials where the mean BMI
of the sample was in the healthy weight range (BMI≥
18 kg/m2 and ≤ 25 kg/m2) and participants were free
from existing medical and psychiatric conditions, partici-




A simple, descriptive bivariate analysis was conducted to
assess the associations between control group weight
change in kilograms, and variables hypothesized to be
potentially associated with control group change (PASW
v.18; SPSS, Chicago, IL). The dependent variable (control
group weight change) was not normally distributed;
therefore non-parametric tests of association were em-
ployed (Mann–Whitney U test or Kruskal-Wallis test for
categorical variables and Spearman rank correlation co-
efficients for continuous variables). Continuous variables
(trial duration, number of assessments undertaken, mean
age and BMI in each trial) were also transformed into
categorical values according to the median value, or an-
other logical value to avoid loss of statistical power in
subsequent analyses as these variables were not normally
distributed and the range of values were small and in-
consistent across all studies.
Meta-analysis and meta-regression
The study protocol adhered to PRISMA guidelines for
reporting systematic reviews and meta-analyses. The
meta-analysis and meta-regression analysis were per-
formed using STATA v.11 (StataCorp, 2009). Publication
bias was investigated visually using a funnel plot and for-
mally by Egger’s and Begg’s tests, using the user-written
“meta” and “metabias” commands. The percentage of
variation attributable to heterogeneity (I2) was computed
from Cochran Q statistic. Given the potential for hetero-
geneity in the studies reviewed, a random effects model
was deemed to be most appropriate. The standard error
(SE) of the primary outcome variable (weight change in
kilograms) was extracted directly from published re-
ports, or computed from the reported standard deviation
(SD), 95% confidence limits or exact p-value. For trials
that did not report mean weight change, but reported
mean group weight (and either SE or SD) at baseline
and follow up, standard errors of weight change were
calculated assuming an intra-correlation coefficient of
ρ= 0.5. P values that were reported as <0.01 or <0.0001
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were replaced by 0.005 and 0.00005 respectively. When
the upper bound <0.01 and <0.0001 were not provided;
we took the mid-point of 0.01 to 0.001 and 0.0001 to
0.00001.
Meta regression (“metareg” command) was performed
to investigate the association between weight change
and trial and sample characteristics that were designated
a priori. The characteristics under investigation were
those included in the bivariate analysis, as well as trial
sample size (n ≥100 or <100) and the method by which
the SE of weight change was determined (reported or
calculated based on SE/SD/exact p-values). Dichoto-
mised categorical versions of continuous variables were
used in the meta-regression analysis to prevent loss of
statistical power. Uni-variable and multi-variable meta-
regression models were carried out. Results are pre-
sented as random effect coefficient estimates with 95%
confidence intervals (CI) and p-values.
Results
Following the removal of duplicates, the total number of
references identified through electronic database search-
ing was 1,467; of which 1,124 were intervention trials
targeting weight loss. Reports of trials in which weight
change was a secondary, and not primary, outcome were
excluded (n = 239); as were studies that reported on the
evaluation of the effectiveness of a surgical procedure,
nutritional or herbal supplement, or pharmacological
treatment (n = 330). Reports of trials without a control
or usual care comparison group (n = 400), and where re-
cruited participants were pregnant, lactating or had a
medical condition that could influence their ability to
lose weight (n = 50) were also excluded. The remaining
105 publications reported the outcomes from 93 individ-
ual behavioural weight loss intervention trials. A further
8 of these were excluded because weight change was re-
ported in a metric other than kilograms or pounds (e.g.,
BMI). Therefore, eighty-five reports of intervention trials
met the inclusion criteria for this review. Seventy-two of
these reports provided either the SE of weight change
for the control group, or sufficient information to allow
for this to be calculated (SE/SD/exact p-value of control
group weight at baseline and follow-up) and were there-
fore included in the meta-regression analysis (Figure 1).
A full list of the intervention trials included in the re-
view is provided in Additional file 1: Appendix 1.
Description of studies included in the review
Trial design and methodology
Sample sizes for the 85 trials included in the review ran-
ged from 15 [14] to 68,591 [15] with a median sample
size of 81 participants. The majority of trials (n = 78;
92%) employed a randomized controlled trial design
with the remaining seven (8%) being quasi-experimental
trials. Detailed accounts of the strategies used to recruit
participants were provided in 76 reports (89%), with over
half of those trials (n = 49; 58%) recruiting participants
through appeals to volunteers via the media or by con-
tacting existing community organisations (such as
schools, workplaces or churches). The remainder (n = 36;
42%) identified participants from existing registers (e.g.,
general practice lists or existing trial cohorts). The dur-
ation between baseline and post-intervention follow up
spanned from six weeks [16] to four and a half years,
[17] with the median duration being 6 months. Control
group participants in all trials were assessed at baseline
and follow up; and at least one additional assessment
was conducted in almost one third of studies (n = 26,
31%). In all but one trial [18], weight was measured ob-
jectively in a clinical setting.
Control group treatment
In 33 trials (39%), participants were allocated to a no
intervention control condition and received no treat-
ment other than undergoing assessment. In a further 14
studies (16%), participants in the control group were
informed that they would receive the intervention at the
completion of the trial (wait list control). Participants in
the comparison group in the remaining 38 studies (44%)
received usual care. The content of the usual care treat-
ment was not consistently described, but most often
involved the receipt of standard off-the-shelf print ma-
terial addressing health behaviours, but may have also
included a single information session delivered in a
group setting or individual consultation.
Characteristics of participants
The mean age of the study sample was reported for 81
trials and varied from 19.2 years [19] to 63.7 years [20].
For those 81 trials, the median of the distribution of
sample ages was 48.7 years. In terms of the gender dis-
tribution within study samples, 24 trials (28%) recruited
only females, and a further 24 trials (28%) recruited
mostly females (≥60% female). In contrast, only seven
trials (8%) exclusively targeted male participants, while
in a further eight trials (9%) males formed more than
60% of the sample. Twenty-two trials (26%) had a rela-
tively even gender distribution (40-60% female). Eighty-
one studies reported the mean BMI for the control
group at baseline, and this value varied from 23.8 kg/m2
[21] to 43.6 kg/m2[22]. The median of the distribution
of BMIs of the control group samples was 31.1 kg/m2.
In three trials (4%), the mean BMI for the control group
was in the healthy weight range, while in the remainder
of studies, the control group sample was either over-
weight (n = 27; 33%) or obese (n = 48, 59%). Of the three
studies where the mean BMI of the control group was in
the healthy weight range, one targeted participants who
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were at high risk of gaining weight, one recruited East
Asian males who met the criteria for overweight when
ethnicity-specific cut-points were used and the remain-
ing study was a family-based study. The majority of stud-
ies targeted participants who were at risk of a chronic
disease through being overweight or obese, but who were
otherwise healthy (n = 55, 65%). Almost one third of
studies (n = 26, 31%) recruited participants who had been
diagnosed with a chronic disease, and a small minority of
studies (n = 4; 5%) targeted healthy populations.
Bivariate analyses
Across all 85 trials, the median weight change for con-
trol groups was negligible (median=+0.1 kg; IQR= −0.85 kg
to +0.8 kg), and ranged from a mean group weight loss
of 5.8 kg [23] to a mean group weight gain of 4 kg [24].
Statistical analyses revealed no significant associations
between control group weight change and the explana-
tory variables (Table 1). While the purpose of this review
was not to quantify the amount of weight change in in-
tervention groups, or to examine factors associated with
greater weight loss among participants who received an
intervention, analyses were repeated for the intervention
groups for comparative purposes to demonstrate dif-
ferences in the average weight change between inter-
vention recipients and controls. The median weight loss
for the intervention groups across all trials was −2.7 kg
(IQR=−5 kg to −1.35 kg; range: -18.7 kg [25] to + 2.5 kg
[26]).
Meta-analysis and meta-regression
A high level of heterogeneity was present (Q = 847.1; df =
71; p = 0.000) with the I2 statistic indicating that 92% of
the variation in control group weight change was attrib-
utable to heterogeneity in the studies reviewed. The re-
sults from the meta-analysis confirmed the findings of
the bivariate analysis. The random effect combined weight
change for the control group was −0.1 kg (95%CI: -0.4,
0.1) and not statistically significantly different from zero
(Figure 2).
In the uni-variable meta-regression model, three vari-
ables were found to be significant predictors of control
group weight change (Table 2). The meta-regression co-
efficient for weight change was significantly lower in
trials with a usual care group compared to those with a
no intervention control group (−0.84 kg; CI:-1.55, -0.13;
p = 0.021); in randomised controlled trials compared to
quasi-experimental trials (−1.11 kg; CI: -2.17, -0.06; p =
0.038) and in trials where the SE of weight change was
derived from the SE/SD/exact p-value (−1.02 kg; CI:
-2.00, -0.03; p = 0.043) as opposed to other methods. In
the multi-variable regression model, the only significant



























Intervention trials targeting 
weight loss
(n =1124) Records excluded
• Weight loss not a primary outcome (n = 239)
• Surgical, nutritional, herbal or 
pharmacological intervention (n = 330)
• No comparison or control group (n = 400)
• Unsuitable target population (n = 50)
Full-text articles assessed for 
eligibility 
(n =105) 
Studies included in review 
(n =85) 
Studies included in quantitative 
synthesis (meta-analysis)
(n =72) 
• 12 Duplicate studies removed  
• 8 studies reporting data in a metric other 
than kilograms or pounds removed
Figure 1 Flow diagram of studies included in the review.
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predictor of control group weight change was control
group treatment with trials with a usual care group hav-
ing a significantly lower meta-regression coefficient for
weight change than trials with a no intervention control
group (−1.23 kg; CI: -2.22, -0.23; p = 0.016) (Table 2).
In comparison, the random effect combined weight
change for the intervention group was −3.36 kg (95%
CI:-3.89, -2.82), and significantly different from zero. In
the uni-variable model, the meta-regression coefficient
for weight change was significantly higher in trials with
a sample size ≥100 (1.95 kg; CI: 0.07, 3.82; p = 0.042),
but none of the explanatory variables were significant
predictors of intervention group weight change in the
multi-variable model (Table 2).
Discussion
This research is novel in providing an understanding
of changes in the behaviour of control groups, rather
than intervention groups. This is the first review to in-
vestigate weight change occurring in control groups in
behavioural weight loss intervention trials, and whether
certain trial or sample characteristics might predict
greater control group weight change. The overall weight
change in control groups was not significantly different
from zero; however, there is some evidence that pro-
viding usual care to control groups may have a greater
effect on weight loss than if no treatment were pro-
vided. Control groups receiving usual care lost signifi-
cantly more weight than no intervention control groups
Table 1 Bivariate associations between explanatory variables and control group weight change (kg)
Trial and participant characteristics: Study n Median group weight change (Inter-quartile range) p-value
Trial Characteristics
Trial design
Randomised controlled trial 78 0.0 (−1.1, 0.8)
Quasi-experimental study design 7 0.5 (−0.2, 0.9) 0.200
Recruitment strategy
Searches of existing registers 36 0.4 (−0.8, 1.25)
Media appeal for volunteers 40 0.0 (−1.1, 0.6) 0.498
Intervention duration*δ
≤6 months 54 0.1 (−0.8, 0.6)
>6 months 31 0.2 (−1.1, 1.9) 0.637
Total number of assessments*
2 (baseline and follow up) 59 0.2 (−0.5, 0.7)
>2 (at least one interim assessment) 26 −0.6 (−1.4, 1.3) 0.468
Control group treatment
No intervention control group 33 0.3 (−0.4, 0.6)
Wait list control group 14 0.4 (−0.4, 2.1)
Usual care group 38 −0.5 (−1.3, 0.8 ) 0.139
Sample Characteristics
Age*
≤50 years 45 0.4 (−1.1, 0.9)
>50 years 36 0.0 (−0.7, 0.8) 0.427
Gender
Mostly female (>60 % female) 48 −0.1 (−1.1, 0.8)
Mixed gender or mostly male 37 0.3 (−0.8, 1.0) 0.346
Target population
Healthy or at risk of chronic disease 59 0.0 (−1.1, 0.6)
Chronic disease 26 0.3 (−0.8, 1.2) 0.247
Baseline mean BMI category
Healthy or overweight (≥ 18 - <25 kg/m2) 33 0.3 (−0.5, 0.8)
Obese (> 30 kg/m2) 48 0.0 (−1.1, 0.9) 0.441
*Dichotomised based on the median value.
δ When analysed as a continuous variable, there was no difference in trial duration for studies that had a mean control group weight loss and those that had a
mean control group weight gain.
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(1.23 kg weight loss compared to no weight change
respectively).
Favourable behaviour changes among control group
participants have been observed for a diverse range of
other health behaviours [7-9]. The fact that these find-
ings were not replicated in the sample of weight loss
intervention trials reviewed is an interesting finding.
There are several plausible explanations for why control
group improvements may be observed in intervention
trials targeting other behaviours, but not those that aim
to change participants’ body weight through employing
behaviour change strategies.
Behavioural weight loss intervention trials are distinct
from those targeting other behaviours in that the pri-
mary outcome is most often physical (i.e., change in
body weight) rather than behavioural (i.e., change in diet
or physical activity). Furthermore, body weight is object-
ively assessed using calibrated scales, as it was in all but
one of the intervention trials reviewed. In contrast, while
objective measures are available for measuring physical
activity and alcohol consumption (two behaviours for
which control group improvements in intervention trials
have been reported), there is a greater reliance on self-
report measures of behaviour change [7,9]. Self-report
measures are susceptible to social desirability bias [27]
and it may be that self-reported behaviour changes in
control groups reflect unreliable reporting rather than
actual behaviour changes. Alternatively, it may be that
control group participants in behavioural weight loss
intervention trials do change their behaviour, but not
sufficient to induce actual weight loss.
Given multiple, inter-related biologic, genetic, social,
and cultural influences, it is difficult to induce behav-
iour changes that lead to sustained weight loss [28,29].
Thus, it is possible that the lack of control group weight
loss observed in this review reflects both the complex-
ity and difficulty in achieving weight loss through be-
havioural strategies alone [12]. Control group changes
may be more likely in intervention trials targeting less
complex behaviours. For example, control group changes
in behavior and objectively measured clinical outcomes
have been seen in intervention trials targeting antiretro-
viral medication adherence [8,30]. The evidence in this
field of research indicates an association between the
quality of usual care treatment and control group out-
comes [30].
Figure 2 Forest plot showing control group weight change (n = 72).
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While the findings of this review appear to suggest
that neither the treatment of the control group, nor the
application of procedures associated with administering
an intervention trial (e.g., measurement, recruitment
strategies) appear sufficient to significantly change parti-
cipants’ body weight, it is possible that control group
participation confers benefits through the prevention of
weight gain. Interventions aimed at preventing weight
gain in healthy populations have become the focus of
research attention in recent years [31,32]. Prospective
studies show that there is a tendency towards weight
gain over time [33,34]. Although the time period consid-
ered in the studies reviewed was likely to be too short to
detect control group weight gain, if weight gain preven-
tion occurred, there would be implications for the devel-
opment of minimal intensity weight gain prevention
interventions. Further research dedicated to understand-
ing which elements of the control group assessment
Table 2 Random effects meta-regression analysis, association of explanatory variables with control group weight
change (kg)
Uni-variable Multi-variable







Method of ascertaining SE of weight change
Reported (ref = 0) 23
From SE/SD/exact p 49 −1.02 (−2.00, -0.03) 0.043 −0.82 (−1.85, 0.21) 0.119
Sample size
<100 (ref = 0) 61
≥100 11 −0.01 (−0.85, 0.83) 0.976 0.68 (−0.32, 1.68) 0.181
Trial design
Quasi-experimental (ref = 0) 6
RCT 66 −1.11 (−2.17, -0.06) 0.038 −0.37 (−1.56, 0.81) 0.538
Recruitment strategy
Media appeal for volunteers (ref = 0) 43
Searches of existing registers 29 −0.03 (−0.71, 0.66) 0.937 −0.13 (−0.62, 0.88) 0.732
Intervention duration
≤6 months (ref = 0) 47
>6 months 25 0.29 (−0.41, 1.00) 0.412 0.72 (−0.17, 1.61) 0.113
Total number of assessments
2 52
>2 (ref = 0) 20 −0.47 (−1.24, 0.30) 0.234 −0.27 (−1.06, 0.51) 0.492
Control group treatment
No intervention control group (ref = 0) 26
Wait list control group 13 0.26 (−0.65, 1.16) 0.579 0.85 (−0.10, 1.80) 0.079
Usual care group 33 −0.84 (−1.55, -0.13) 0.021 −1.23 (−2.22, -0.23) 0.016
Age
≤50 years (ref = 0) 34
>50 years 35 −0.01 (−0.71, 0.69) 0.971 −0.32 (−1.07, 0.43) 0.406
Gender
Mixed gender or mostly male (ref = 0) 33
Mostly female (>60 % female) 39 −0.22 (−0.90, 0.45) 0.517 0.14 (−0.56, 0.84) 0.695
Target population
Chronic disease (ref = 0) 23
Healthy or at risk of chronic disease 49 −0.38 (−1.09, 0.32) 0.286 −0.49 (−1.26, 0.29) 0.216
Baseline BMI category
Healthy or overweight (≤ 30 kg/m2) (ref = 0) 26
Obese (> 30 kg/m2) 43 −0.24 (−0.96, 0.48) 0.513 −0.24 (−0.95, 0.47) 0.501
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might be useful for weight gain prevention (research
procedures, the content of usual care, or the interaction
between the two) is warranted.
This review has a number of limitations. First, the
results of the meta-analysis must be interpreted with
caution, given the extent of heterogeneity observed. This
review was limited to intervention trials published be-
tween 2005 and 2010. The decision to limit the review
to papers published within this timeframe was made for
practical purposes as the literature addressing behav-
ioural weight loss interventions is vast. It is possible that
the results of this study may have been impacted by the
decision to limit the review to this timeframe. It is also
not possible to exclude publication bias given the reli-
ance on published manuscripts. A large number of ex-
planatory variables were included in the meta-regression
model, potentially increasing the probability of false
positive conclusions. However, this is unlikely to have
been a problem, given that very few of the explanatory
variables were significantly associated with the outcome
variable. A more parsimonious model containing a fewer
explanatory variables yielded similar results. The usual
care treatment delivered to participants in the control
group was often not described comprehensively, pre-
cluding analysis of the effects of the content of usual
care treatment on control group outcomes. The absence
of sufficient information to enable replication of the
usual care condition has been noted in previous studies
and is a barrier to understanding control group improve-
ments [8,30,35]. However, given the overall null findings
related to weight change, the utility of such an analysis
would be questionable in the context of this review.
Conclusions
Contrary to other areas of behaviour change research
where control group improvements have been observed
[7-9], in behavioural weight loss interventions control
groups mostly showed negligible changes in weight sta-
tus. The findings of this review suggest that it is difficult
to achieve weight loss, and exposure to measurement
alone is insufficient to initiate measureable behaviour
change. Minimal intensity interventions may have a role
in a range of health behaviours but appear not to do so
with respect to weight loss.
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